Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tajikistan Tech Daily.
Press releases published on September 3, 2025

Lyell Immunopharma Announces the Initiation of a Phase 3 Head-to-Head CAR T-Cell Therapy Clinical Trial in Aggressive Large B-Cell Lymphoma and Formation of Expert Steering Committee
PiNACLE - H2H will evaluate rondecabtagene autoleucel (ronde-cel) versus investigator’s choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving treatment in the second line (2L) setting Ronde-cel is Lyell’s …

Duos Edge AI Awarded Patent
JACKSONVILLE, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …

Genius Group CEO Roger Hamilton to speak at H.C. Wainwright 27th Annual Global Investment Conference
SINGAPORE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced its CEO, Roger Hamilton, will be speaking at the H.C. Wainwright …

Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance
Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March 31, 2025, and June 30, 2025, respectively, in accord with its August 11, 2025 updated Nasdaq compliance plan. Company also announces notification by Nasdaq …

K12 Robotics League Opens Nationwide Registration for 2025–26 Season
RESTON, Va., Sept. 03, 2025 (GLOBE NEWSWIRE) -- K12, a national leader in online K–12 education, today announced the launch of the 2025–26 K12 Robotics League season. Open to students nationwide in grades 4 through 12, the competition offers an opportunity …

UBiqube เร่งประสิทธิภาพการส่งมอบ SASE ด้วยการเปิดตัว SASE OpsLab Automation Marketplace
กรุงดับลิน วันที่ , Sept. 03, 2025 (GLOBE NEWSWIRE) -- UBiqube ผู้นำระดับโลกด้านการประสานงานและระบบอัตโนมัติโครงสร้างพื้นฐานไอทีแบบหลายโดเมน เปิดตัว SASE OpsLab ตลาดสำหรับโซลูชันระบบอัตโนมัติ SecOps ที่จะพลิกโฉมวิธีการส่งมอบและดำเนินการ SASE ในปัจจุบัน …

Nobel Laureate Dr. Ardem Patapoutian Joins Stratus Scientific Advisory Board
Dr. Ardem Patapoutian, PhD, is a recipient of the Nobel Prize in Physiology or Medicine in 2021 for his work characterizing the PIEZO1 and PIEZO2 receptors that detect touch, pressure, and proprioception Dr. Patapoutian’s landmark discoveries underpin the …

Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- SOUTH SAN FRANCISCO, Calif., September 2, 2025 — Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its …

Echobit Secures Czech VASP License and Partners with Coinone to Enhance Crypto Deposit and Withdrawal Services
Singapore, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Echobit exchange has reached a “dual milestone” in its global compliance journey — obtaining a Virtual Asset Service Provider (VASP) registration in the Czech Republic and forming a strategic partnership with …

Free Mark Cuban Foundation AI Bootcamp Coming to Philadelphia This Fall
PHILADELPHIA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, will host a no-cost Artificial Intelligence Bootcamp for high school students in Philadelphia this fall. The program is open to students in grades 9–12 and …

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer’s Disease Reaches 75% Enrollment Target
PURCHASE, N.Y., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study has …

BridgeBio to Host Autosomal Dominant Hypocalcemia Type 1 (ADH1) Investor Webinar on Wednesday, September 10th at 8:00 am ET
PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced the Company will host an investor webinar on …

Shock Top and Auntie Anne’s® Make It Official - Beer Kneads Pretzels
ATLANTA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Shock Top, a craft beer icon and brand by Tilray Brands, Inc. company (NASDAQ: TLRY and TSX: TLRY), known for its bold flavors and unfiltered wheat ales, and the world’s largest hand-rolled soft pretzel franchise …

XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference
EMERYVILLE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today its Chief Executive Officer, Owen Hughes, and Chief Investment Officer, Brad Sitko, will present a company …

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a …

Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland
This marks the first export of organic certified flower for SMGH, 20th international market for Aureus branded products and 23rd market for all Avicanna products TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: …

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) First-ever demonstration of therapeutically restored …

Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose
VAX-31 Optimized Dose, with Majority of Serotypes Dosed at 4.4mcg and Balance at 3.3mcg, is Designed to Elicit Even Stronger Immune Responses in Infant Population to Protect Against Invasive Pneumococcal Disease (IPD) Company Intends to Release Topline …

MicrobiotiX Finalizes KRW 20 Billion Series B, Securing Korea's First Bacteriophage Clinical Trial
SEOUL, South Korea, Sept. 03, 2025 (GLOBE NEWSWIRE) -- MicrobiotiX, a biotech developing novel bacteriophage-based therapeutics, announced on the 29th that it has completed an extended Series B investment round totaling 20 billion KRW. MicrobiotiX’s …

Apogee Therapeutics to Participate at the Stifel 2025 Virtual Immunology and Inflammation Forum
SAN FRANCISCO and BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), today announced that members of management will participate in a fireside chat at the Stifel 2025 Virtual Immunology and Inflammation Forum on Tuesday, …